API5: Difference between revisions
Jump to navigation
Jump to search
m Bot: HTTP→HTTPS |
imported>OAbot m Open access bot: add pmc identifier to citation with #oabot. |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
The human [[gene]] '''API5''' encodes the [[protein]] '''Apoptosis inhibitor 5'''.<ref name="pmid9307294">{{cite journal |vauthors=Tewari M, Yu M, Ross B, Dean C, Giordano A, Rubin R | title = AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal | journal = Cancer | The human [[gene]] '''API5''' encodes the [[protein]] '''Apoptosis inhibitor 5'''.<ref name="pmid9307294">{{cite journal | vauthors = Tewari M, Yu M, Ross B, Dean C, Giordano A, Rubin R | title = AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal | journal = Cancer Research | volume = 57 | issue = 18 | pages = 4063–9 | date = September 1997 | pmid = 9307294 | pmc = | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: API5 apoptosis inhibitor 5| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8539| access-date = }}</ref> | ||
This gene encodes an [[apoptosis]] inhibitory protein whose expression prevents apoptosis after [[growth factor]] deprivation. This protein suppresses the [[transcription factor]] E2F1-induced apoptosis and also interacts with, and negatively regulates acinus, a [[Cell nucleus|nuclear]] factor involved in apoptotic [[DNA]] fragmentation. Its depletion enhances the [[Cytotoxicity|cytotoxic]] action of [[Chemotherapy|chemotherapeutic]] drugs. | This gene encodes an [[apoptosis]] inhibitory protein whose expression prevents apoptosis after [[growth factor]] deprivation. This protein suppresses the [[transcription factor]] E2F1-induced apoptosis and also interacts with, and negatively regulates acinus, a [[Cell nucleus|nuclear]] factor involved in apoptotic [[DNA]] fragmentation. Its depletion enhances the [[Cytotoxicity|cytotoxic]] action of [[Chemotherapy|chemotherapeutic]] drugs. Crystal structure of API5 exhibited the function for protein-protein interaction <ref>{{cite journal | vauthors = Han BG, Kim KH, Lee SJ, Jeong KC, Cho JW, Noh KH, Kim TW, Kim SJ, Yoon HJ, Suh SW, Lee S, Lee BI | title = Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules | journal = The Journal of Biological Chemistry | volume = 287 | issue = 14 | pages = 10727–37 | date = March 2012 | pmid = 22334682 | doi = 10.1074/jbc.M111.317594 | pmc = 3322819 }}</ref> | ||
Diseases associated with API5 include colon [[adenocarcinoma]], and [[cervical cancer]]. | Diseases associated with API5 include colon [[adenocarcinoma]], and [[cervical cancer]]. | ||
== References== | |||
==References== | |||
{{reflist}} | {{reflist}} | ||
== Further reading == | |||
==Further reading== | |||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Gianfrancesco F, Esposito T, Ciccodicola A, D'Esposito M, Mazzarella R, D'Urso M, Forabosco A | title = Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene | journal = Cytogenetics and Cell Genetics | volume = 84 | issue = 3-4 | pages = 164–6 | year = 1999 | pmid = 10393420 | doi = 10.1159/000015247 }} | |||
* {{cite journal | vauthors = Kim JW, Cho HS, Kim JH, Hur SY, Kim TE, Lee JM, Kim IK, Namkoong SE | title = AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis | journal = Laboratory Investigation; A Journal of Technical Methods and Pathology | volume = 80 | issue = 4 | pages = 587–94 | date = April 2000 | pmid = 10780674 | doi = 10.1038/labinvest.3780008 }} | |||
*{{cite journal |vauthors=Gianfrancesco F, Esposito T, Ciccodicola A |title=Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene | * {{cite journal | vauthors = Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H, Bugler B | title = FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2 | journal = Molecular Endocrinology | volume = 14 | issue = 11 | pages = 1709–24 | date = November 2000 | pmid = 11075807 | doi = 10.1210/me.14.11.1709 }} | ||
*{{cite journal |vauthors=Kim JW, Cho HS, Kim JH |title=AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis | * {{cite journal | vauthors = Sutherland HG, Mumford GK, Newton K, Ford LV, Farrall R, Dellaire G, Cáceres JF, Bickmore WA | title = Large-scale identification of mammalian proteins localized to nuclear sub-compartments | journal = Human Molecular Genetics | volume = 10 | issue = 18 | pages = 1995–2011 | date = September 2001 | pmid = 11555636 | doi = 10.1093/hmg/10.18.1995 }} | ||
*{{cite journal |vauthors=Van den Berghe L, Laurell H, Huez I |title=FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2 | * {{cite journal | vauthors = Li Z, Hu CY, Mo BQ, Xu JD, Zhao Y | title = [Effect of beta-carotene on gene expression of breast cancer cells] | journal = Ai Zheng = Aizheng = Chinese Journal of Cancer | volume = 22 | issue = 4 | pages = 380–4 | date = April 2003 | pmid = 12703993 | doi = }} | ||
*{{cite journal |vauthors=Sutherland HG, Mumford GK, Newton K |title=Large-scale identification of mammalian proteins localized to nuclear sub-compartments | * {{cite journal | vauthors = Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M | title = Nucleolar proteome dynamics | journal = Nature | volume = 433 | issue = 7021 | pages = 77–83 | date = January 2005 | pmid = 15635413 | doi = 10.1038/nature03207 }} | ||
* {{cite journal | vauthors = Kim JE, Tannenbaum SR, White FM | title = Global phosphoproteome of HT-29 human colon adenocarcinoma cells | journal = Journal of Proteome Research | volume = 4 | issue = 4 | pages = 1339–46 | year = 2005 | pmid = 16083285 | doi = 10.1021/pr050048h }} | |||
*{{cite journal |vauthors=Li Z, Hu CY, Mo BQ |title=[Effect of beta-carotene on gene expression of breast cancer cells] |journal=Ai Zheng |volume=22 |issue= 4 |pages= 380–4 | | * {{cite journal | vauthors = Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M | title = Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | journal = Cell | volume = 127 | issue = 3 | pages = 635–48 | date = November 2006 | pmid = 17081983 | doi = 10.1016/j.cell.2006.09.026 }} | ||
* {{cite journal | vauthors = Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW, Dyson NJ | title = Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo | journal = PLoS Genetics | volume = 2 | issue = 11 | pages = e196 | date = November 2006 | pmid = 17112319 | pmc = 1636698 | doi = 10.1371/journal.pgen.0020196 }} {{open access}} | |||
*{{cite journal |vauthors=Andersen JS, Lam YW, Leung AK |title=Nucleolar proteome dynamics | * {{cite journal | vauthors = Han BG, Kim KH, Lee SJ, Jeong KC, Cho JW, Noh KH, Kim TW, Kim SJ, Yoon HJ, Suh SW, Lee S, Lee BI | title = Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules | journal = J Biol Chem | volume = 287 | pages = 10727-37 | doi = 10.1074/jbc.M111.317594 | pmc = 3322819 }} | ||
*{{cite journal |vauthors=Kim JE, Tannenbaum SR, White FM |title=Global phosphoproteome of HT-29 human colon adenocarcinoma cells | |||
*{{cite journal |vauthors=Olsen JV, Blagoev B, Gnad F |title=Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | |||
*{{cite journal |vauthors=Morris EJ, Michaud WA, Ji JY |title=Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo | |||
}} | |||
{{refend}} | {{refend}} | ||
Latest revision as of 22:47, 22 May 2018
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
The human gene API5 encodes the protein Apoptosis inhibitor 5.[1][2]
This gene encodes an apoptosis inhibitory protein whose expression prevents apoptosis after growth factor deprivation. This protein suppresses the transcription factor E2F1-induced apoptosis and also interacts with, and negatively regulates acinus, a nuclear factor involved in apoptotic DNA fragmentation. Its depletion enhances the cytotoxic action of chemotherapeutic drugs. Crystal structure of API5 exhibited the function for protein-protein interaction [3]
Diseases associated with API5 include colon adenocarcinoma, and cervical cancer.
References
- ↑ Tewari M, Yu M, Ross B, Dean C, Giordano A, Rubin R (September 1997). "AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal". Cancer Research. 57 (18): 4063–9. PMID 9307294.
- ↑ "Entrez Gene: API5 apoptosis inhibitor 5".
- ↑ Han BG, Kim KH, Lee SJ, Jeong KC, Cho JW, Noh KH, Kim TW, Kim SJ, Yoon HJ, Suh SW, Lee S, Lee BI (March 2012). "Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules". The Journal of Biological Chemistry. 287 (14): 10727–37. doi:10.1074/jbc.M111.317594. PMC 3322819. PMID 22334682.
Further reading
- Gianfrancesco F, Esposito T, Ciccodicola A, D'Esposito M, Mazzarella R, D'Urso M, Forabosco A (1999). "Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene". Cytogenetics and Cell Genetics. 84 (3–4): 164–6. doi:10.1159/000015247. PMID 10393420.
- Kim JW, Cho HS, Kim JH, Hur SY, Kim TE, Lee JM, Kim IK, Namkoong SE (April 2000). "AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis". Laboratory Investigation; A Journal of Technical Methods and Pathology. 80 (4): 587–94. doi:10.1038/labinvest.3780008. PMID 10780674.
- Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H, Bugler B (November 2000). "FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2". Molecular Endocrinology. 14 (11): 1709–24. doi:10.1210/me.14.11.1709. PMID 11075807.
- Sutherland HG, Mumford GK, Newton K, Ford LV, Farrall R, Dellaire G, Cáceres JF, Bickmore WA (September 2001). "Large-scale identification of mammalian proteins localized to nuclear sub-compartments". Human Molecular Genetics. 10 (18): 1995–2011. doi:10.1093/hmg/10.18.1995. PMID 11555636.
- Li Z, Hu CY, Mo BQ, Xu JD, Zhao Y (April 2003). "[Effect of beta-carotene on gene expression of breast cancer cells]". Ai Zheng = Aizheng = Chinese Journal of Cancer. 22 (4): 380–4. PMID 12703993.
- Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M (January 2005). "Nucleolar proteome dynamics". Nature. 433 (7021): 77–83. doi:10.1038/nature03207. PMID 15635413.
- Kim JE, Tannenbaum SR, White FM (2005). "Global phosphoproteome of HT-29 human colon adenocarcinoma cells". Journal of Proteome Research. 4 (4): 1339–46. doi:10.1021/pr050048h. PMID 16083285.
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (November 2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW, Dyson NJ (November 2006). "Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo". PLoS Genetics. 2 (11): e196. doi:10.1371/journal.pgen.0020196. PMC 1636698. PMID 17112319. open access publication – free to read
- Han BG, Kim KH, Lee SJ, Jeong KC, Cho JW, Noh KH, Kim TW, Kim SJ, Yoon HJ, Suh SW, Lee S, Lee BI. "Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules". J Biol Chem. 287: 10727–37. doi:10.1074/jbc.M111.317594. PMC 3322819.